ng-nitroarginine methyl ester and Adrenal Cancer

ng-nitroarginine methyl ester has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barthélemy, C; Carayon, A; Eurin, J; Masson, F; Sarfati, E; Soualmia, H	1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Adrenal Cancer

Article	Year
Bradykinin-induced neuropeptide Y release by human pheochromocytoma tissue. Neuropeptides, 2002, Volume: 36, Issue:4 Topics: Adrenal Gland Neoplasms; Bradykinin; Calcium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; In Vitro Techniques; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pheochromocytoma; Receptor, Bradykinin B2; Receptors, Bradykinin; Stimulation, Chemical	2002

Article

Year

Bradykinin-induced neuropeptide Y release by human pheochromocytoma tissue.

Neuropeptides, 2002, Volume: 36, Issue:4

Topics: Adrenal Gland Neoplasms; Bradykinin; Calcium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; In Vitro Techniques; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pheochromocytoma; Receptor, Bradykinin B2; Receptors, Bradykinin; Stimulation, Chemical

2002